355 related articles for article (PubMed ID: 35742820)
1. How to Restore Oxidative Balance That Was Disrupted by SARS-CoV-2 Infection.
Kiełbowski K; Herian M; Pawlik A
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742820
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
3. Cytokine storm in individuals with severe COVID-19 decreases endothelial cell antioxidant defense via downregulation of the Nrf2 transcriptional factor.
Rodrigues D; Machado MR; Alves JV; Fraga-Silva TFC; Martins RB; Campos LCB; Francisco DF; Couto AES; Bonato VLD; Arruda E; Becari C; Auxiliadora-Martins M; Louzada-Júnior P; Costa RM; Tostes RC
Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H252-H263. PubMed ID: 37327001
[TBL] [Abstract][Full Text] [Related]
4. The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy.
Kouhpayeh S; Shariati L; Boshtam M; Rahimmanesh I; Mirian M; Esmaeili Y; Najaflu M; Khanahmad N; Zeinalian M; Trovato M; Tay FR; Khanahmad H; Makvandi P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064039
[TBL] [Abstract][Full Text] [Related]
5. Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19.
Yong YY; Zhang L; Hu YJ; Wu JM; Yan L; Pan YR; Tang Y; Yu L; Law BY; Yu CL; Zhou J; Li M; Qin DL; Zhou XG; Wu AG
Clin Immunol; 2022 Nov; 244():109093. PubMed ID: 35944881
[TBL] [Abstract][Full Text] [Related]
6. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities.
Alam MS; Czajkowsky DM
Cytokine Growth Factor Rev; 2022 Feb; 63():44-57. PubMed ID: 34836751
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway.
Hamad RS; Al-Kuraishy HM; Alexiou A; Papadakis M; Ahmed EA; Saad HM; Batiha GE
Cell Stress Chaperones; 2023 Nov; 28(6):657-673. PubMed ID: 37796433
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Liskova A; Samec M; Koklesova L; Samuel SM; Zhai K; Al-Ishaq RK; Abotaleb M; Nosal V; Kajo K; Ashrafizadeh M; Zarrabi A; Brockmueller A; Shakibaei M; Sabaka P; Mozos I; Ullrich D; Prosecky R; La Rocca G; Caprnda M; Büsselberg D; Rodrigo L; Kruzliak P; Kubatka P
Biomed Pharmacother; 2021 Jun; 138():111430. PubMed ID: 33662680
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection.
Qu Y; Haas de Mello A; Morris DR; Jones-Hall YL; Ivanciuc T; Sattler RA; Paessler S; Menachery VD; Garofalo RP; Casola A
Microbiol Spectr; 2023 Jun; 11(3):e0037823. PubMed ID: 37022178
[TBL] [Abstract][Full Text] [Related]
11. Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?
Menegazzi M; Campagnari R; Bertoldi M; Crupi R; Di Paola R; Cuzzocrea S
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708322
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
Chong ZZ; Souayah N
Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
[TBL] [Abstract][Full Text] [Related]
13. Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal.
Batiha GE; Al-Kuraishy HM; Al-Gareeb AI; Alruwaili M; AlRuwaili R; Albogami SM; Alorabi M; Saad HM; Simal-Gandara J
Inflammopharmacology; 2023 Feb; 31(1):1-7. PubMed ID: 36418600
[TBL] [Abstract][Full Text] [Related]
14. Mixed storm in SARS-CoV-2 infection: A narrative review and new term in the Covid-19 era.
Alomair BM; Al-Kuraishy HM; Al-Gareeb AI; Al-Buhadily AK; Alexiou A; Papadakis M; Alshammari MA; Saad HM; Batiha GE
Immun Inflamm Dis; 2023 Apr; 11(4):e838. PubMed ID: 37102645
[TBL] [Abstract][Full Text] [Related]
15. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
Sasidharakurup H; Kumar G; Nair B; Diwakar S
OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
[TBL] [Abstract][Full Text] [Related]
16. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
[TBL] [Abstract][Full Text] [Related]
17. Glutathione deficiency in the pathogenesis of SARS-CoV-2 infection and its effects upon the host immune response in severe COVID-19 disease.
Labarrere CA; Kassab GS
Front Microbiol; 2022; 13():979719. PubMed ID: 36274722
[TBL] [Abstract][Full Text] [Related]
18. Disengaging the COVID-19 Clutch as a Discerning Eye Over the Inflammatory Circuit During SARS-CoV-2 Infection.
Anwar MM; Sah R; Shrestha S; Ozaki A; Roy N; Fathah Z; Rodriguez-Morales AJ
Inflammation; 2022 Oct; 45(5):1875-1894. PubMed ID: 35639261
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
20. The possible role of nuclear factor erythroid-2-related factor 2 activators in the management of Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Eldahshan OA; Abdelkhalek YM; El Dahshan M; Ahmed EA; Sabatier JM; Batiha GE
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23605. PubMed ID: 38069809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]